Melatonin role in skeletal muscle disorders

被引:10
|
作者
Salucci, S. [1 ]
Taurone, S. [2 ]
Burattini, S. [1 ]
Gobbi, P. [1 ]
Clausi, J. [1 ]
Battistelli, M. [1 ]
机构
[1] Carlo Bo Urbino Univ, Dept Biomol Sci, Urbino, Italy
[2] Sapienza Univ Rome, Dept Sensory Organs, Rome, Italy
关键词
Melatonin; Skeletal muscle; Muscle disorders; MITOCHONDRIAL PERMEABILITY TRANSITION; OXIDATIVE STRESS; ANTIOXIDANT ENZYMES; SIGNALING PATHWAYS; CELL-DEATH; SARCOPENIA; APOPTOSIS; REGENERATION; DYSFUNCTION; MECHANISMS;
D O I
10.26355/eurrev_202101_24672
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: This review discusses the impact of the neuro-hormone melatonin on skeletal muscle disorders based on recent literature data with the aim to clarify the utility of the melatonin therapy in patients affected by muscle diseases. MATERIALS AND METHODS: It has been pointed out the possible role of melatonin as a food supplement to cure muscular disorders characterized by muscle wasting. Oxidative damage has been proposed as one of the major contributors of the skeletal muscle decline occurring both in physiological and pathological conditions. It is known that excessive oxidant levels lead to mitochondria! damage, and in turn. contribute to apoptotic signaling activation and autophagic impairment. This condition is common in a variety of skeletal muscle disorders. RESULTS: The scientific evidence enhances the antioxidant effect of melatonin, that has been demonstrated by several studies both in vitro and in vivo. This effect counteracts mitochondria) impairments and reduces oxidative stress and autophagic alterations in muscle fibers. Its beneficial role in restoring muscle decline, takes place mainly in atrophic conditions correlated to muscle aging. CONCLUSIONS: The findings of the research suggest that melatonin may be considered as a valid dietary supplement, useful to prevent muscle wasting, in particular, in sarcopenia-associated diseases.
引用
收藏
页码:1024 / 1033
页数:10
相关论文
共 50 条
  • [1] The regulatory role of melatonin in skeletal muscle
    Chen, Bide
    You, Wenjing
    Shan, Tizhong
    [J]. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2020, 41 (2-3) : 191 - 198
  • [2] The regulatory role of melatonin in skeletal muscle
    Bide Chen
    Wenjing You
    Tizhong Shan
    [J]. Journal of Muscle Research and Cell Motility, 2020, 41 : 191 - 198
  • [3] Skeletal disorders associated with skin pigmentation: a role of melatonin?
    Abdel-Wanis, ME
    Kawahara, N
    [J]. MEDICAL HYPOTHESES, 2003, 61 (5-6) : 640 - 642
  • [4] Protective role of melatonin on skeletal muscle injury in rats
    Mehanna, Radwa A.
    Soliman, Gehan Y.
    Hassaan, Passainte S.
    Sharara, Gehan M.
    Abdel-Moneim, Rehab A.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 1490 - 1501
  • [5] The role of skeletal muscle biopsy in the diagnosis of neuromuscular disorders
    Nadaj-Pakleza, Aleksandra
    Kierdaszuk, Biruta
    Kaminska, Anna
    [J]. NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2010, 44 (05) : 481 - 491
  • [6] Impact of Melatonin on Skeletal Muscle and Exercise
    Stacchiotti, Alessandra
    Favero, Gaia
    Rodella, Luigi Fabrizio
    [J]. CELLS, 2020, 9 (02)
  • [7] DISORDERS OF SKELETAL MUSCLE
    DURSTON, JHJ
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 1974, 11 (04): : 590 - &
  • [8] The role of β-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders
    Koopman, Rene
    Ryall, James G.
    Church, Jarrod E.
    Lynch, Gordon S.
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2009, 12 (06): : 601 - 606
  • [9] The Functional Role of Calcineurin in Hypertrophy, Regeneration, and Disorders of Skeletal Muscle
    Sakuma, Kunihiro
    Yamaguchi, Akihiko
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [10] Taurine and Skeletal Muscle Disorders
    Diana Conte Camerino
    Domenico Tricarico
    Sabata Pierno
    Jean-François Desaphy
    Antonella Liantonio
    Michael Pusch
    Rosa Burdi
    Claudia Camerino
    Bodvael Fraysse
    Annamaria De Luca
    [J]. Neurochemical Research, 2004, 29 : 135 - 142